患者样品在生化试剂批次变更后检验结果一致性中的应用

Yunxiu Wang, Haibiao Lin, Ze-min Wan, Weiye Chen, Xiaobin Wu
{"title":"患者样品在生化试剂批次变更后检验结果一致性中的应用","authors":"Yunxiu Wang, Haibiao Lin, Ze-min Wan, Weiye Chen, Xiaobin Wu","doi":"10.3760/CMA.J.ISSN.1007-1245.2014.24.001","DOIUrl":null,"url":null,"abstract":"Objective To study the role of clinical patient samples in verifying consistency of clinical results between different reagent lots.Methods The results of 5 clinical samples,Roche quality control materials and Biorad quality control materials for 13 clinical routine biochemical tests were obtained by using both old and new reagent lot,and performed the statistics.The bias of 13 measurands were computed after changing reagent lots,and also were judged according to the 1/3 limits of CLIA' 88 defined acceptable error,whether the bias was conform to clinical requirements or not.Results QC material results had no significant difference between two reagent lots (P > 0.05).The results of ALT,UA,TC and ApoA for patient samples had significant difference (P < 0.05),but the bias of these items were within the 1/3 limits of CLIA' 88 defined acceptable error,which were 2.57%,4.41%,1.81% and 3.84% respectively,in accordance with clinical requirement.Conclusions As there is matrix effect of quality control materials,the results for QC materials should not be used to verify the consistency of results for patient samples when changing reagent lots.To overcome this situation,we should use quality control materials together with clinical samples to compare consistency of results after changing reagent lots. \n \nKey words: \nLots of reagents;  Clinical samples;  Quality control materials;  Matrix effect","PeriodicalId":14405,"journal":{"name":"国际医药卫生导报","volume":"20 1","pages":"3663-3666"},"PeriodicalIF":0.0000,"publicationDate":"2014-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of patient samples in verifying results consistency after biochemistry reagent lot change\",\"authors\":\"Yunxiu Wang, Haibiao Lin, Ze-min Wan, Weiye Chen, Xiaobin Wu\",\"doi\":\"10.3760/CMA.J.ISSN.1007-1245.2014.24.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective To study the role of clinical patient samples in verifying consistency of clinical results between different reagent lots.Methods The results of 5 clinical samples,Roche quality control materials and Biorad quality control materials for 13 clinical routine biochemical tests were obtained by using both old and new reagent lot,and performed the statistics.The bias of 13 measurands were computed after changing reagent lots,and also were judged according to the 1/3 limits of CLIA' 88 defined acceptable error,whether the bias was conform to clinical requirements or not.Results QC material results had no significant difference between two reagent lots (P > 0.05).The results of ALT,UA,TC and ApoA for patient samples had significant difference (P < 0.05),but the bias of these items were within the 1/3 limits of CLIA' 88 defined acceptable error,which were 2.57%,4.41%,1.81% and 3.84% respectively,in accordance with clinical requirement.Conclusions As there is matrix effect of quality control materials,the results for QC materials should not be used to verify the consistency of results for patient samples when changing reagent lots.To overcome this situation,we should use quality control materials together with clinical samples to compare consistency of results after changing reagent lots. \\n \\nKey words: \\nLots of reagents;  Clinical samples;  Quality control materials;  Matrix effect\",\"PeriodicalId\":14405,\"journal\":{\"name\":\"国际医药卫生导报\",\"volume\":\"20 1\",\"pages\":\"3663-3666\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"国际医药卫生导报\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1007-1245.2014.24.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"国际医药卫生导报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1007-1245.2014.24.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的研究临床患者标本在验证不同试剂批次间临床结果一致性中的作用。方法对5份临床样品、Roche质控材料和Biorad质控材料进行13项临床常规生化试验,采用新旧试剂批次,并进行统计。更换试剂批号后计算13项测量的偏倚,并根据CLIA’88定义的可接受误差的1/3限判断偏倚是否符合临床要求。结果两批试剂的质控结果差异无统计学意义(P < 0.05)。患者样本的ALT、UA、TC和ApoA结果差异有统计学意义(P < 0.05),但这些项目的偏倚分别为2.57%、4.41%、1.81%和3.84%,均在CLIA’88定义的可接受误差的1/3范围内,符合临床要求。结论质控品存在基质效应,在更换试剂批次时,不应使用质控品的结果来验证患者样品结果的一致性。为了克服这种情况,我们应该将质控材料与临床样品一起使用,以比较更换试剂批次后结果的一致性。关键词:大量试剂;临床样本;质量控制材料;基体效应
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Application of patient samples in verifying results consistency after biochemistry reagent lot change
Objective To study the role of clinical patient samples in verifying consistency of clinical results between different reagent lots.Methods The results of 5 clinical samples,Roche quality control materials and Biorad quality control materials for 13 clinical routine biochemical tests were obtained by using both old and new reagent lot,and performed the statistics.The bias of 13 measurands were computed after changing reagent lots,and also were judged according to the 1/3 limits of CLIA' 88 defined acceptable error,whether the bias was conform to clinical requirements or not.Results QC material results had no significant difference between two reagent lots (P > 0.05).The results of ALT,UA,TC and ApoA for patient samples had significant difference (P < 0.05),but the bias of these items were within the 1/3 limits of CLIA' 88 defined acceptable error,which were 2.57%,4.41%,1.81% and 3.84% respectively,in accordance with clinical requirement.Conclusions As there is matrix effect of quality control materials,the results for QC materials should not be used to verify the consistency of results for patient samples when changing reagent lots.To overcome this situation,we should use quality control materials together with clinical samples to compare consistency of results after changing reagent lots. Key words: Lots of reagents;  Clinical samples;  Quality control materials;  Matrix effect
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
26723
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信